메뉴 건너뛰기




Volumn 44, Issue 8, 2009, Pages 3266-3271

A new type of five-membered heterocyclic inhibitors of basic metallocarboxypeptidases

Author keywords

1,3,4 Oxadiazole; High throughput screening; Human carboxypeptidase B; Metallocarboxypeptidase; Molecular docking; Protease M14 family

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; CARBOXYPEPTIDASE B; METALLOCARBOXYPEPTIDASE INHIBITOR; METALLOPROTEINASE INHIBITOR; N (3 CHLOROPHENYL) 4 [[5 (3 METHOXYBENZYLTHIO) 1,3,4 OXADIAZOL 2 YL]METHYL]THIAZOL 2 AMINE; UNCLASSIFIED DRUG;

EID: 67349104395     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.03.034     Document Type: Article
Times cited : (12)

References (44)
  • 1
    • 20444460605 scopus 로고    scopus 로고
    • Metallocarboxypeptidases
    • Messerschmidt A., Bode W., and Cygler M. (Eds), John Wiley and Sons Ltd., Chichester
    • Vendrell J., Aviles F.X., and Fricker L.D. Metallocarboxypeptidases. In: Messerschmidt A., Bode W., and Cygler M. (Eds). Handbook of Metalloproteins (2004), John Wiley and Sons Ltd., Chichester 176-189
    • (2004) Handbook of Metalloproteins , pp. 176-189
    • Vendrell, J.1    Aviles, F.X.2    Fricker, L.D.3
  • 10
    • 67349173430 scopus 로고    scopus 로고
    • P. Cronet, W. Knecht, C.A.-C. Malmborg Hager, M. Andersson, C. Furebring, Sequences of modified human carboxypeptidase U (CPU) with increased thermal stability for treating hemorrhage disorders, Astrazeneca AB, Swed, Astrazeneca UK Limited, Application: WO. Patent No. 2005052149, 2005
    • P. Cronet, W. Knecht, C.A.-C. Malmborg Hager, M. Andersson, C. Furebring, Sequences of modified human carboxypeptidase U (CPU) with increased thermal stability for treating hemorrhage disorders, Astrazeneca AB, Swed., Astrazeneca UK Limited, Application: WO. Patent No. 2005052149, 2005.
  • 11
    • 67349178014 scopus 로고    scopus 로고
    • Diagnostics and therapeutics for diseases associated with human carboxypeptidase A3 based on tissue expression profiling, Bayer Healthcare AG, Germany,
    • Application: WO. Patent No. 2006010495
    • S. Golz, U. Brueggemeier, A. Geerts, Diagnostics and therapeutics for diseases associated with human carboxypeptidase A3 based on tissue expression profiling, Bayer Healthcare AG, Germany, Application: WO. Patent No. 2006010495, 2006.
    • (2006)
    • Golz, S.1    Brueggemeier, U.2    Geerts, A.3
  • 12
    • 67349178014 scopus 로고    scopus 로고
    • Diagnostics and therapeutics for diseases associated with human carboxypeptidase A2 based on tissue expression profiling, Bayer Healthcare AG, Germany,
    • Application: WO. Patent No. 2006010499
    • S. Golz, U. Brueggemeier, A. Geerts, Diagnostics and therapeutics for diseases associated with human carboxypeptidase A2 based on tissue expression profiling, Bayer Healthcare AG, Germany, Application: WO. Patent No. 2006010499, 2006.
    • (2006)
    • Golz, S.1    Brueggemeier, U.2    Geerts, A.3
  • 25
    • 44949104716 scopus 로고    scopus 로고
    • Smith D.H. Drugs 68 (2008) 1207-1225
    • (2008) Drugs , vol.68 , pp. 1207-1225
    • Smith, D.H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.